inclusion criteria: 1. laboratory-confirmed covid-19 with in 72 hours prior to randomization 2. respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow 3. understands and agrees to comply with planned study procedures 4. agrees to the collection of venous blood per protocol 5. must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized

inclusion criteria: 1. laboratory-confirmed covid-19 with in 72 hours prior to randomization 2. respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow 3. understands and agrees to comply with planned study procedures 4. agrees to the collection of venous blood per protocol 5. must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized

inclusion criteria: laboratory-confirmed covid-19 with in 72 hours prior to randomization respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow understands and agrees to comply with planned study procedures agrees to the collection of venous blood per protocol must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized

inclusion criteria: laboratory-confirmed covid-19 with in 72 hours prior to randomization respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow understands and agrees to comply with planned study procedures agrees to the collection of venous blood per protocol must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized

inclusion criteria: 1. laboratory-confirmed covid-19 with in 72 hours prior to randomization 2. respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow 3. understands and agrees to comply with planned study procedures 4. agrees to the collection of venous blood per protocol 5. must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized

inclusion criteria: 1. laboratory-confirmed covid-19 with in 72 hours prior to randomization 2. respiratory symptoms or abnormal lung exam or abnormal chest imaging and oxygen saturation ≤94% on room air, or requiring supplemental oxygen less than 50% high flow 3. understands and agrees to comply with planned study procedures 4. agrees to the collection of venous blood per protocol 5. must agree to be placed on prophylactic dose of anticoagulation for prevention of deep venous thrombosis (dvt) while hospitalized